Companies: 10,795·Total market cap: $144.5T

TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc.

TLSINASDAQHealthcare● Active

$3.21

+$0.04(+1.26%)

Market Cap$121691610

P/E Ratio—

52W High$7.95

52W Low$2.2

Avg Volume367K

Open$3.13

Beta0.49

Net Income Financials Revenue

TriSalus Life Sciences, Inc. (TLSI) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

TLSI · net income · updated Jun 9, 2026

Core profitability metrics

TLSI · net income · margin · TTM · CAGR

Net income was −$39.2M for FY2025 (fiscal year ending 2025-12-31), down 18.0% year-over-year. Net profit margin was -86.9%.

FY2025 Net Income−$39.2M▼ -18.0% YoY

Trailing 12M (TTM)−$27.3Mtrailing 4 quarters sum

Net Profit Margin-86.9%−$39.2M ÷ $45.2M

YoY Change-18.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · TLSI net income history · TLSI profit margin

Annual net income data

TLSI · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$39.2M▼ 18.0%-86.9%$45.2M

FY2024Loss−$33.2M▲ +44.0%-112.9%$29.4M

FY2023Loss−$59.4M▼ 25.8%-320.7%$18.5M

FY2022Loss−$47.2M▼ 63.6%-380.6%$12.4M

FY2021Loss−$28.8M▲ +9.4%-343.4%$8.4M

Net income vs peers (Healthcare)

TLSI vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

TriSalus Life Sciences, Inc.YOU

TLSI

−$39.2M-18.0%-86.9%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

TriSalus Life Sciences, Inc. (TLSI) reported net income of −$39.2M for FY2025 (fiscal year ending 2025-12-31), down 18.0% year-over-year. The net profit margin was -86.9% — meaning the company kept $-0.87 of every dollar of revenue as profit.

TriSalus Life Sciences, Inc. has not yet achieved annual profitability based on available data (6 fiscal years). The company has reported net losses across all available periods.

TriSalus Life Sciences, Inc.'s net profit margin was -86.9% for FY2025, based on the latest annual results.

Investors sometimes search for "TriSalus Life Sciences, Inc. net worth" — the company's market capitalization is a separate figure from TLSI net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

TLSI net income · 4 questions

TriSalus Life Sciences, Inc. is not currently profitable on an annual basis. The company reported a net loss of $39.2M for FY2025.

is TLSI profitabledoes TLSI make a profitTLSI profitabilityTLSI profitable company

▸ Source: FMP /income-statement · GAAP · TriSalus Life Sciences, Inc. · TriSalus Life Sciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026